Economics of PE care: Study pinpoints cost disparities between PE treatment modalities
A new resource utilisation study of adult pulmonary embolism (PE) admissions spanning more than two decades shows that the highest cost treatment modalities were...
First patients in Italy treated with VVT Med’s ScleroSafe system
VVT Med recently shared that the first group of patients in Italy has been treated with the ScleroSafe system. The patients were treated by...
M3 Medical expands into the UK endovenous market with leading global partners
M3 Medical, part of the Uniphar Medtech Group, recently announced that it has launched its endovenous portfolio into the UK market.
A press release notes...
VVT Med announces positive clinical data for ScleroSafe published
VVT Med has announced the publication of a peer-reviewed clinical study evaluating the short-term efficacy and safety of its ScleroSafe catheter-directed sclerotherapy system. The...
